The continued growth in demand for mini tablets (micro-tablets or mini-tabs) is hardly surprising given the benefits that they can deliver for healthcare professionals and their patients. Their small...

Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Featuring...

CARBOGEN AMCIS has announced that two of its manufacturing sites in Switzerland have passed inspections completed by the U.S. Food and Drug Administration (FDA). The sites in Neuland and...

Broken String Biosciences (Broken String) has announced the appointment of its new Chief Commercial Officer, Steve Becker. The newly appointed CCO will help the genomics company strive towards boosting its...

Nine innovative businesses are celebrating receiving 857,000 GBP in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme – the first Innovate UK programme of its...

Enterprise Therapeutics (Enterprise) has successfully administered ETD001 to an individual with Cystic Fibrosis. The biopharmaceutical company is focused on developing therapies to help improve the lives of those suffering...

Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G, an siRNA therapeutics targeting...

Lario Therapeutics reveals that it has been awarded a $6 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The programme is in collaboration with the Oxford...

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab...

SynaptixBio, the only company licensed to commercialise a treatment for a rare, incurable and deadly disease, has today announced it is extending its collaboration agreement with Evotec, a leading life...

As the Life Sciences industry comes to depend increasingly on excellent technology and data for speed, efficiency and competitive advantage, it’s more important than ever that companies harness validation...

The Optimal Group is advancing automated laboratory analysis processes across the pharmaceutical sector with the launch of the SciYbotic Labs range. The new solutions make analysis faster with a...

Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. The data required to help address these challenges already...

Praxis Packaging Solutions has selected  Systech to provide a track-and-trace platform that aims to improve supply chain transparency. Through the collaboration, Praxis’ customers will have access to high-quality aggregation and enhanced...

Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimise raw data and turn it into actionable insights for...

SPT Labtech’s firefly all-in-one liquid platform has been selected by PRISM BioLab to help the Japanese biotechnology company accelerate the design of small molecule inhibitors of protein-protein interaction targets....

Building on success of GW pharmaceuticals, the UK has the potential to become the global leader in pharmaceutical cannabinoid R&D, according to a new report published by the Cannabinoid...

Veranova has announced the appointment of its new Senior Vice President, Chief Commercial Officer, Cécile Maupas. The API manufacturer for the pharmaceutical and biotech sectors has also recently unveiled...

Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C...

Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways. Research recently published by Nova One Advisor indicates that...

Systech has selected Praxis Packaging Solutions to provide a track-and-trace platform that aims to improve supply chain transparency. Through the collaboration, Praxis’ customers will have access to high-quality aggregation...

Brenntag Specialities Pharma has opened its new Good Manufacturing Practice (GMP) compliant packaging service line. Located in Guntramsdorf, the facility offers repackaging services for clients across Europe with a...

Upperton Pharma Solutions, a contract development and manufacturing organisation (CDMO), has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned...

Mogrify has appointed Dr Jonathan Appleby as its new Chief Scientific Officer. Dr Appleby, who has decades of experience translating both conventional and advanced therapeutic medicines, aims to advance...

Global packaging leader, Berry Global Group, Inc. has introduced a range of special closures and couplings which can be used in conjunction with its popular Politainer combi pack. This provides a...

CPHI South East Asia (10-12th July 2024) returns to Queen Sirikit National Convention Centre in the heart of Bangkok, as the industry undergoes improving prospects driven by increasing pharmaceutical development...

MedPharm, an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners portfolio company, jointly announced a merger. The combined topical and transepithelial Contract Development and Manufacturing Organisation (CDMO)...

Mini-tabs offer unprecedented flexibility in drug delivery, but not without significant challenges. The pharmaceutical industry is seeing a significant surge in demand for mini-tablets, also known as micro-tablets or...

Scenic Biotech has announced the appointment of Ben Machielse to its board of directors. Machielse has over 25 years of experience within the biotech industry, specifically in the development...

After the launch of French startup Bioptimus less than five months ago, the company has unveiled its H-optimus-0, which is an open-source AI foundation model for pathology. With 1.1...

Envirotainer, a specialist in temperature-sensitive pharmaceutical shipments, has announced significant enhancements to its testing capabilities, with the addition of three new testing chambers. With the capability to test a wider...

ChargePoint Technology is expanding its presence in India, and has announced the launch of its new subsidiary, ChargePoint UK Private Ltd.  The subsidiary will focus on business development and providing...

Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, has announced that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss (lebrikizumab) for use in...

In this episode, you can hear Olivia Friett, editor of Medical Plastics News talk to Scott Nelson, FastWave Medical, about the complete start-up journey – covering the initial idea,...

VectorY Therapeutics, a biotech company developing innovative vectorised antibody therapies for the treatment of neurodegenerative diseases, has announced the appointment of Adam Rosenberg as the new Chair of the Board....

Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, has launched DIAMIND Sentry, a solution allowing pharma companies to efficiently manage...

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed a novel method capable of...

ILiAD Biotechnologies has selected Emmes Group to conduct the upcoming Phase III clinical trials on its leading pertussis vaccine candidate, BPZE1. Emmes, a global contract research and technology company,...

NLC Health Ventures, in collaboration with Verily, a precision health technology company, will launch Exolvo Biosciences, a pioneering biotech company delivering the next-generation solution for biologic drug delivery. Through Exolvo, NLC...

CPHI Europe will return to Messe Frankfurt in 2025, scheduled for 28-30th October. The event will bring together the entire supply chain, from ingredients and finished dosages to machinery, bio,...

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, has announced a new agreement with AstraZeneca, a global biopharmaceutical company, to evaluate...

Discovery Park welcomed experts in healthy ageing to its Innovation Summit on 20th June, calling for the life science network in Kent to join forces to make the county...

Torbay Pharma (TP), an independent pharma manufacturer, has announced that CEO, Emma Rooth, has won the Inspiring Change Leader of the Year at the Women in Change Awards. The company says...

Edinburgh-based 1nhaler has appointed two experts in inhalation and respiratory medicines to the board as it looks to accelerate the development and market-readiness of its single-use inhaler device. Jane...

A British manufacturing firm has introduced technologies that “promise to revolutionise” drug testing in the medical and pharmaceutical sectors. IPFL’s micro 3D printing services enable the production of intricate...

With the global injectable pharma market projected to soar to $762.48 billion by 2028, secondary pharmaceutical packaging specialist MM Packaging urges the industry to embrace smart packaging technology for enhanced...

Almirall S.A., a global pharmaceutical company dedicated to medical dermatology, has launched its new sustainability strategy, Act4Impact 2030.  The updated strategy aims at transforming the company’s sustainability roadmap and focuses on five...

PSG Biotech, a product brand of PSG, has unveiled its new SumoFlo CELE-8103-D Integral Display Transmitter. The pump and flow meter technology provider’s latest launch features a 144×144 mm four-line...

Rhenopharma Group has acquired Konapharma AG, a Swiss contract manufacturer for the pharmaceutical industry. Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem,...

Rosemont Pharmaceuticals has acquired Pharma-Data S.A, a privately owned Research and Development Organisation based in Lavrion, Greece. Pharma-Data specialises in Research & Development (R&D) and the development of Value-Added Medicinal...

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer, has announced initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study...

Bio-Rad has extended its anti-biotherapeutic antibodies range to now include anti-idiotypic antibodies for the atezolizumab (Lemtrada), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ocrelizumab (Ocrevus) drugs. Additionally, the life science research...

Stability testing is a vital element of ensuring a drug product is compliant with regulatory requirements, irrespective of whether you are submitting to the Food and Drug Administration (FDA),...

Cytiva has launched its Supor Prime sterilising grade filters to filtrate high-concentration biologic drugs. The latest addition to the life sciences leader’s portfolio aims to help drug developers achieve...

This GLP-1R / CRE Luciferase Reporter HEK293 cell line has been engineered to monitor activation of GLP-1R in cells by measuring luciferase activity, making it useful for cell-based binding assays...

Labguru (BioData) announces an agreement with Thermo Fisher Scientific to enable the distribution of its Labguru Electronic Lab Notebook (ELN) module alongside Thermo Fisher’s suite of Laboratory Information Management System (LIMS) and lab operations...

Thermo Fisher Scientific has introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the ‘only’ fully automated maxi-scale plasmid DNA (pDNA) purification system. PlasmidPro enables innovation at scale, providing complete automation across mini...

Aurorium, a specialty ingredients manufacturer and materials innovation partner, has announced the launch of Haelium Pharmaceutical Solutions.  “The launch of the Haelium brand will more clearly represent our position in...

TurboFil Packaging Machines, an equipment specialist dedicated solely to the design and development of liquid filling and assembly machines, is collaborating with Bridgewater, NJ-based Amneal Pharmaceuticals to develop an...

Bora Pharmaceuticals has announced that it has successfully entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of a major commercial expansion for the Company....

In this episode of The MedTalk Podcast, Olivia Friett the editor of Medical Plastics News, is joined by Adrian Jennings, chief product officer at Cognosos, to discuss how tracking...

Allecra Therapeutics (also known as Allecra) and Acino have signed an exclusive licensing agreement which allows Acino to commercialise the antibiotic drug EXBLIFEP in the Republic of South Africa and members...

Discovery Park has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses,...

England’s top doctor has backed calls from NHS Blood and Transplant (NHSBT) for O Positive and O Negative blood donors to urgently book appointments to donate in one of...

Regarding the integration of Telstar into Syntegon after an acquisition agreement closed between Azbil Corporation and the German company which has been announced by both firms, Telstar expresses that...

ACG has announced a strategic partnership with EY-Parthenon aiming to enhance ACG’s sustainability initiatives through a comprehensive Net Zero strategy and implementation roadmap aligned with the Science Based Targets...

Written by: Adriano Leuzzi – Head of Process Development; Angelo Raggioli – Head of Technology Development, ReiThera. The field of gene therapy is witnessing unprecedented growth, offering promising avenues for...

Johnson & Johnson Innovative Medicine have announced its strengthened commitment in Italy, with a projected investment of €580 million over the next five years, of which €125 million will support...

Merck have announced an investment of €62 million at its Darmstadt headquarters in a new quality control building for its Life Science business. The facility will bring together approximately 135...

We caught up with Purolite’s Felix Solamo to look back on Bio International 2024 and what it meant for the Company.  EPM: What new products or innovations did your...

iOnctura have announced that it has closed an €80 million Series B financing. The funding round was led by new investor Syncona Limited with participation by the EIC Fund, the venture...

Written by: Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services. While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing...

Written by: Dr Maxim Polyakov, Senior Vice President, Business Intelligence and Research at M3. Pharmaceutical products play in a highly competitive field. Understanding the HCP target audience through market research is...

Written by: Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm, Withers & Rogers. Investing in the development of cell and gene therapies (CGTs)...

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for...

Lyphe Clinic has announced a partnership with Gro-Vida, a licensed medical cannabis cultivar. This collaboration marks a significant step forward in advancing patient care and access to high-quality medical cannabis products...

Haier Biomedical has launched the wide neck CryoBio series, a new generation of liquid nitrogen containers offering convenient access to stored samples. This latest addition to the CryoBio range also features an...

Cherwell has introduced a new Redipor Plastic Bottle prepared media range in response to a request from a large pharmaceutical company for support in meeting its sustainability targets. The new terminally sterilised plastic...

Written by: Dr Sylvain Lacomble, Vice President Europe Middle East & Africa, Terumo Blood and Cell Technologies.  Blood and its components are essential medicines, utilised for a wide range of...

UPS Healthcare has announced an expansion of its European hub facility in Roermond, the Netherlands by 21,860 sqm, adding in-demand freezer farm capacity, a crucial link in a strong...

Big pharma behemoths Johnson & Johnson has agreed a payment of $700 million to settle allegations that the Company mislead its customers about the safety of its talc-based products. ...

The European Commission’s Health Emergency Preparedness and Response Authority (HERA) as part of its mandate on preparedness, has signed on behalf of participating Member States, a joint procurement framework...

Laboratory equipment supplier Scientific Laboratory Supplies (SLS) has opened the new SLS National Distribution Centre (NDC) at the Fairham Business Park, Nottingham, as it looks to kickstart its next phase...

Sage Therapeutics announced topline results from the Phase 2 SURVEYOR Study. The study met its primary endpoint demonstrating a statistically significant difference as measured by the HD-Cognitive Assessment Battery (HD-CAB)...

Benchling, the R&D Cloud powering the biotech industry, have announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 scientists from 30 teams.  Benchling is working with Sanofi...

Cycle Pharmaceuticals a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, have confirmed that it made a proposal to the Board of Directors...

Last week, AstraZeneca announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). The acquisition marks a major step forward in...

Syngene International have announced the launch of its new protein production platform. The platform, using a cell line and transposon-based technology in-licensed from Swiss biotech services company, ExcellGene, coupled with...

Vetter have announced its plans to move and expand its Development Services site from Skokie, Illinois, to Des Plaines, further investing in its U.S. footprint. Simultaneously, the company plans...

Alchemab Therapeutics has been awarded a grant of $595,000 by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its Parkinson’s disease program. The grant will fund...

Aragen Bioscience and Getinge have announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant antibody production. This collaboration combines Aragen’s expertise in biopharmaceutical manufacturing and Getinge’s innovative...

Nuclera have announced it has been awarded two highly competitive Innovate UK grants totalling £1.14M. The funding, made up of a £790k flexible, agile, scalable, and sustainable technologies (FASST) grant awarded...

MediMab Biotherapeutics has opened a new state-of-the-art facility, developed by Kadans Science Partner, at Sovereign House, Abingdon Science Park, UK. The purpose-built building, including state-of-the-art CL2 wet labs, will support...

Thermo Fisher Scientific has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced...

Seres Therapeutics has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full...

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced its financial results for year ending 30 September 2023. Figures released show the company recorded a $93...

Ecolab have announced that its Purolite resin business, together with Repligen Corporation has commercially launched Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes. This new affinity...

Ardena have announced the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive Officer. Jeremie is a seasoned executive in the pharmaceutical Contract Development and...

Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, have announced plans to invest $100 million to expand into plasmid DNA (pDNA) production. The centerpiece of the...

Sanofi have completed the acquisition of Inhibrx. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s rare disease pipeline, underscoring the company’s commitment to pursuing differentiated and potential best-in-class medicines...

DefiniGEN and Atelerix have announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant...

Johnson & Johnson have announced it has entered into a definitive agreement with Numab Therapeutics to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to NM26, in an all-cash...

Owkin has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia to develop and commercialise OKN4395, a clinic-ready best-in-class dual inhibitor of...

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneX) have announced the launch of a new Drug Discovery Division. This further expands the CDMOs...

POA Pharma Scandinavia AB, a speciality pharmaceutical company with expertise across multiple therapeutic areas, has announced the launch of PKU Easy Microtabs Plus in Austria.  This marks the latest...

Kerry Pickstone, Partner at operations transformation consultancy Argon & Co. discusses the impact of the new anti-espionage laws in China, weighing how Western pharmaceutical firms can embed resilience into their...

MSD and Eyebiotech have announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio. “We continue to execute on our science-led...

Secarna Pharmaceuticals and Orbit Discovery have announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics. The collaboration will leverage Orbit’s expertise...

AGC Biologics and BioConnection, a specialised CMO focusing on aseptic filling of vials and syringes for clinical and commercial production, have announced a new strategic partnership. They are partnering to provide...

The European Commission has approved, under EU State aid rules, the first Important Project of Common European Interest to support research, innovation and the first industrial deployment of healthcare products,...

LabGenius has closed a £35 million Series B financing round. The investment brings LabGenius’ total funding to date to £58 million. The round was led by new investor M Ventures...

Bio-Sourcing, with partners Ciloa and Intract Pharma, have announced the launch of a €3.4M ($3.7M) EU-funded program, including €1.9M in subsidies from EUREKA Eurostars. The three-year AB-BIOBETTER project aims...

Germfree and Orgenesis Inc. have announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programs and its suite of product development and GMP cell processing services. The collaboration’s goal...

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver...

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together...

Aktis Oncology have announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform. The collaboration draws on Aktis’ proprietary radiopharmaceutical...

Biogen and Human Immunology Biosciences (HI-Bio) have announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to...

Orna Therapeutics have announced its acquisition of ReNAgade Therapeutics, a pioneer in unlocking the potential of RNA therapeutics that demonstrated industry-leading delivery to multiple extra-hepatic cells in non-human primate (NHP)...

Nona Biosciences have announced that it has entered into a license agreement with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology. “We are delighted...

SGD Pharma has invested more than €20 million to upgrade its Zhanjiang plant in China. The refurbishment involves a complete rebuild of its furnace and comprehensive improvement of the plant’s...

Merck has signed a definitive agreement to acquire life science company Mirus Bio for $600 million. Mirus Bio is a specialist in the development and commercialisation of transfection reagents. Transfection reagents, such as...

Serum Institute of India (SII) has announced a strategic investment in IntegriMedical, acquiring a 20% stake in the company, to advance Needle-Free Injection System technology. The partnership between SII and...

Johnson & Johnson have announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in...

Serum Institute of India marks a significant milestone with the shipment of its first set of R21/Matrix-M malaria vaccine to Africa. The initial shipment will be sent to the Central African Republic...

Pharmaceutical packaging is changing, with patient preferences and evolving legislation working in tandem to drive sustainability to the top of the agenda. The need to introduce more environmentally responsible...

Pheon Therapeutics, a leading Antibody-Drug Conjugate specialist developing next generation ADCs for a wide range of hard-to-treat cancers, have announced the completion of a $120m Series B financing to fund the...

Oxford BioDynamics and The London Clinic, one of the UK’s leading private hospitals, have signed an agreement to give The London Clinic patients access to OBD’s EpiSwitch PSE (EpiSwitch Prostate...

To discuss the recent news from Exothera that the company are expand into North America, we at EPM caught up with Darren Leva, Chief Business Officer, Exothera.  EPM: Can you...

Cresset is expanding its existing Asia Pacific presence by creating a new headquarters in Bangalore, one of India’s leading centres for biotechnology and pharmaceutical research.  This latest announcement consolidates...

UK-based Contract Research Organisation Gentronix has been awarded the King’s Award for Enterprise after achieving a triple-figure revenue growth following rapid expansion in international markets. Gentronix recorded total growth of...

Up to now, the sheer amount of work required in bringing intelligent automation systems up to speed and validating them for life sciences R&D purposes, e.g. to transform adverse...

Oxford BioDynamics have announced it is collaborating with the King’s College London team in the immediate follow up of  the APIPPRA trial, the largest RA prevention trial to date. The APIPPRA...

Johnson & Johnson and Shockwave Medical have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave corresponding to an enterprise value of approximately $13.1...

Saint-Gobain Life Sciences has opened a state-of-the-art production facility at Magna Business Park in Citywest. The new facility will enable Saint-Gobain Life Sciences to increase production and further expand its...

GSK will become the first founding partner of the Fleming Initiative, an innovative and collaborative approach led by Imperial College Healthcare NHS Trust and Imperial College London to tackle antimicrobial...

Closed Loop Medicine and Pharmanovia have announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment. OptiZest will investigate whether patients with hypertension can improve blood pressure control at...

NeuroSense Therapeutics have announced that it partnered with PhaseV, a pioneer in causal machine learning for clinical trial analysis and optimisation, with respect to the planned Phase 3 trial of...

AbbVie and Gilgamesh Pharmaceuticals have announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie’s expertise in psychiatry and Gilgamesh’s innovative...

BBI Solutions OEM Limited (BBI) has signed a partnership agreement with BioAgilytix. The partnership will integrate BBI’s ability to efficiently produce high-quality custom antibody reagents for a variety of...

Western blots are frequently included in pharmaceutical research papers to report results when analysing proteins in a sample. However, research shows that Western blot images are a common source...

Ajax Therapeutics, Inc. have announced the closing of an oversubscribed $95 million Series C financing. Proceeds from the financing will be used to support the clinical development of Ajax’s first-in-class...

Entia’s new, home-use, full blood count analyser that provides personalised and preventative care for cancer patients outside of hospital has been approved for use in the UK. The unique analyser...

ArgusEye have announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB). The...

Ensuring patient adherence to medication is a crucial factor in delivering better health outcomes for patients – but adherence for chronic disease is just 50 per cent globally, leading...

Frank Jäger has been appointed Commercial Director of the newly created CCL Clinical business unit. “The fact that the world’s largest label manufacturer, CCL Label, is setting up a...

Sanofi’s has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US. The terms of the agreement include: a co-exclusive license to co-commercialise Novavax’s current...

Santander UK has provided Ennogen Healthcare International, a growing UK based pharmaceuticals manufacturer, with a £30 million loan facility to support its international expansion plans. Established in 2011, Ennogen...

Ribobay Pharma, a leading Chinese biopharmaceutical CRDMO and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory...

Metaphore Biotechnologies have joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management. Under the terms of the...

Teva Pharmaceuticals and Medincell have announced results from the efficacy portion of the Phase 3 Subcutaneous OLAnzapine extended-Release Injection Study (SOLARIS) trial evaluating TEV-‘749 in adult patients with schizophrenia...

Regeneron Pharmaceuticals have announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11 months of age) within 24 weeks, and initial hearing...

Lantern Pharma have announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase (PDI) inhibitor drug candidate XCE853 in novel and targeted cancer...

Pfizer have announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive...

Broken String Biosciences have announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and...

AstraZeneca have announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced in November 2023 will leverage the...

Johnson & Johnson have announced it is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK. The announcement...

Boston Micro Fabrication (BMF) has introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale...

Bio-Rad Laboratories have announced the launch of three new StarBright Red Dyes — StarBright Red 715, 775, and 815 — and an expansion of its StarBright Violet Dye series with 29...

Production and QC Challenges with mini-tabs The continued growth in demand for mini tablets (micro-tablets or mini-tabs) is hardly surprising given the benefits that they can deliver for healthcare...

Cormica, has completed the seven-figure purchase of TPM Laboratories (TPM) in New Jersey. Cormica, backed by Limerston Capital, is focused on strategically expanding its capabilities across the U.S and...

Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with...

Bespak and H&T Presspart have announced a collaboration to accelerate the industry’s transition from existing pressurised Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilising low global warming potential...

AbbVie breaks ground on a new central research building, “LUnA” (LUdwighafens neue Arbeitswelt) and is investing approximately €150 million in its second largest R&D location worldwide. A state-of-the-art research...

Neurocrine Biosciences have announced the U.S. FDA has approved INGREZZA SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and...

UV radiation poses a significant threat to our skin, with melanin pigments providing partial protection by absorbing and reflecting incoming radiation. Drawing inspiration from this natural defence, TLX Cargo...

Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of...

Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector...

PlaqueTec have announced that it has secured $8 million USD equity financing, led by Lord Moynihan of Chelsea alongside the Future Fund, with support from existing investors. The funding...

The pre-filled syringe (PFS) market is growing rapidly, driven by the rising need for innovative biologics and a desire for self-administration treatment options offering greater convenience. This increased demand...

Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners. As part of...

Novartis have announced that the National Institute for Health and Care Excellence has published its Final Draft Guidance (FDG) recommending the combination therapy of dabrafenib with trametinib, within its...

Written by: Miroslav Hlaučo, Apheresis Network Manager, SCTbio. In recent years, there have been an increasing number of clinical trials and research projects based on cell technologies that use cells...

Ascendis Pharma have announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration to research, develop and commercialise in vivo CRISPR-based gene editing therapies for multiple tissues and cell types.  Regeneron is developing adeno-associated viral vectors (AAVs) using...

Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very...

Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites. Following the opening...

Novartis have announced that the U.S. Food and Drug Administration (FDA) approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12...

Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. The funding is comprised of a $5 million equity investment to advance Owlstone’s Breath Biopsy...

In our latest Pharma Explained we look explore what Monkeypox is, how it impacts the body, and the larger-scale issues associated with the disease.

JOIN THE EXPERTS: MAY 28 2024 | 10.00 (EDT) | 15.00 (BST) | 16.00 (CEST) Join Prometheus Group for a vital live webinar on how pharmaceutical companies can enhance their competitive edge...

Benchling announced that Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data, collaboration,...

BioArctic AB and Eisai have entered into a research evaluation agreement regarding BAN2802, a potential new treatment combining BioArctic’s proprietary BrainTransporter technology with an undisclosed Alzheimer drug candidate. At the...

Imugene have announced a strategic manufacturing and process development partnership, which includes the sale of Imugene’s North Carolina Current Good Manufacturing Practice (CGMP) manufacturing facility and the transfer of process...

Neurolentech, have announced a technology access partnership with Kaerus Bioscience. The agreement enables Kaerus Bioscience to access Neurolentech’s NDD Drug Discovery platform and leverage its proprietary cell models and assays...

Veeva Systems have announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications. “Our customers are exploring...

Ferring Pharmaceuticals and SK pharmteco have announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin (nadofaragene firadenovec-vncg) for ensuring long-term future...

FUJIFILM Corporation have announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly...

GSK have announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate. The Prescription...

In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success...

Roche have announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell...

Ardena has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility. The facility includes state-of-the-art GMP-compliant cleanrooms to...

Recently, the European Medicines Agency (EMA)’s drug safety committee, PRAC, evaluated and analysed the potential risk of side effects in individuals who have used the GLP-1 class of drugs....

Across the biopharmaceutical industry, many have expressed concern about the protracted timelines for drug development, which on average are getting longer when most stakeholders insist the time to market...

On April 15th, Novartis presented results from a pre-specified interim analysis of the Phase III APPLAUSE-IgAN study of Fabhalta (iptacopan), an investigational Factor B inhibitor of the alternative complement pathway,...

MSD has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for...

A new report on e-labelling from the International Pharmaceutical Federation (FIP) has highlighted the importance of regulation and collaboration as the transition towards digital labelling gathers pace.  The report outlines the...

SK Life Science, a subsidiary of SK Biopharmaceuticals, have announced that the U.S. Food and Drug Administration (FDA) approved two new administration options of XCOPRI (cenobamate tablets) CV, an antiseizure...

In a historic move, Nigeria has become the first country in the world to roll out a new Men5CV vaccine recommended by the World Health Organization (WHO), which protects people against...

Seaport Therapeutics, a clinical-stage biopharmaceutical company that is charting a proven path in neuropsychiatry, have announced the closing of a $100 million oversubscribed Series A financing round. The round...

Oligonucleotide therapies offer a targeted approach to modulating gene expression, splicing, and protein production. By selectively manipulating specific molecular processes, these therapies hold the potential to treat a wide...